이속사졸린(Isoxazoline) 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The Isoxazoline Market size is expected to reach USD 12.08 Billion in 2034 from USD 5.57 Billion (2025) growing at a CAGR of 8.98% during 2026-2034.

The global isoxazoline market is growing steadily due to its widespread application in veterinary medicine, particularly for controlling parasites in companion animals. Isoxazolines are commonly used in flea and tick treatments for pets, offering long-lasting protection and high efficacy. Increasing pet ownership and rising awareness about animal health are key factors driving the demand for these products globally.

Key drivers include the growing trend of pet humanization, increased spending on pet healthcare, and advancements in veterinary pharmaceuticals. Pharmaceutical companies are developing innovative oral and topical formulations that provide extended protection against parasites. Additionally, the expansion of veterinary services and improved access to pet care products in emerging markets are further boosting market growth.

Looking forward, the isoxazoline market is expected to witness strong growth with continuous product innovation and expanding applications. The development of combination treatments targeting multiple parasites will enhance product appeal. As pet adoption continues to rise globally, especially in urban areas, the demand for effective and convenient parasite control solutions will remain robust.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product Type

• Fluralaner
• Afoxolaner
• Sarolaner
• Lotilaner

By Pet Type

• Dog
• Cat

COMPANIES PROFILED

• Sigma Aldrich Inc, Carbanio, Boehringer Ingelheim International GmbH, Elanco Animal Health Inc, Merck Animal Health Inc, Zoetis Inc, Virbac SA, CevaSant Animale, Dechra Pharmaceuticals PLC, Vetoquinol SA
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL ISOXAZOLINE MARKET: BY PRODUCT TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product Type
• 4.2. Fluralaner Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Afoxolaner Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Sarolaner Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Lotilaner Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL ISOXAZOLINE MARKET: BY PET TYPE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Pet Type
• 5.2. Dog Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Cat Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL ISOXAZOLINE MARKET: BY REGION 2022-2034 (USD MN)

• 6.1. Regional Outlook
• 6.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.2.1 By Product Type
  • 6.2.2 By Pet Type
  • 6.2.3 United States
  • 6.2.4 Canada
  • 6.2.5 Mexico
• 6.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.3.1 By Product Type
  • 6.3.2 By Pet Type
  • 6.3.3 United Kingdom
  • 6.3.4 France
  • 6.3.5 Germany
  • 6.3.6 Italy
  • 6.3.7 Russia
  • 6.3.8 Rest Of Europe
• 6.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.4.1 By Product Type
  • 6.4.2 By Pet Type
  • 6.4.3 India
  • 6.4.4 Japan
  • 6.4.5 South Korea
  • 6.4.6 Australia
  • 6.4.7 South East Asia
  • 6.4.8 Rest Of Asia Pacific
• 6.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.5.1 By Product Type
  • 6.5.2 By Pet Type
  • 6.5.3 Brazil
  • 6.5.4 Argentina
  • 6.5.5 Peru
  • 6.5.6 Chile
  • 6.5.7 Rest of Latin America
• 6.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.6.1 By Product Type
  • 6.6.2 By Pet Type
  • 6.6.3 Saudi Arabia
  • 6.6.4 UAE
  • 6.6.5 Israel
  • 6.6.6 South Africa
  • 6.6.7 Rest of the Middle East And Africa

Chapter 7. COMPETITIVE LANDSCAPE

• 7.1. Recent Developments
• 7.2. Company Categorization
• 7.3. Supply Chain & Channel Partners (based on availability)
• 7.4. Market Share & Positioning Analysis (based on availability)
• 7.5. Vendor Landscape (based on availability)
• 7.6. Strategy Mapping

Chapter 8. COMPANY PROFILES OF GLOBAL ISOXAZOLINE INDUSTRY

• 8.1. Top Companies Market Share Analysis
• 8.2. Company Profiles
  • 8.2.1 Sigma Aldrich Inc
  • 8.2.2 Carbanio
  • 8.2.3 Boehringer Ingelheim International GmbH
  • 8.2.4 Elanco Animal Health Inc
  • 8.2.5 Merck Animal Health Inc
  • 8.2.6 Zoetis Inc
  • 8.2.7 Virbac SA
  • 8.2.8 Ceva Sante Animale
  • 8.2.9 Dechra Pharmaceuticals PLC
  • 8.2.10 Vetoquinol SA